How do we characterize and localize Astigmatisms within the optical pathway?

Discussion in 'ODwire.org TV & Radio' started by AdminWolf, Jun 6, 2018.

  1. AdminWolf

    AdminWolf Site Administrator & Tech Lead
    Staff Member

    13,762
    Messages
    Joined:
    Feb 24, 2001
    School/Org:
    University of Michigan Medical School
    City:
    Lake Oswego
    State:
    OR


    Question 5: How do we characterize and localize Astigmatisms within the optical pathway?

    with:
    Larry Patterson, MD
    Mitch Jackson, MD
    Cynthia Matossian, MD
    Neda Shamie, MD
    Toby Tyson, MD


    Thanks to Marco for letting me re-post this; I realize the panel and the video was aimed at OMDs primarily, but so much of the discussion is highly relevant to ODs. -- adam

    -----

    Other videos from the Power Forum III:
    Question 1: How does data from Angles Alpha & Kappa, Corneal SA, Coma, pupil size, and Corneal vs. Lenticular Astigmatism improve your premium IOL selections and outcomes?

    Question 2: What wavefront data should you use to select EDOF IOLs for patients?


    Question 3: What are the multi-function benefits of using an integrated Wavefront Aberrometer, registered on the patient’s optical center?


    Question 4: When OSD is discovered prior to surgery, should you postpone the procedure for treatment, or stabilize the tear film, then proceed with surgery?

    Question 5: How do we characterize and localize Astigmatisms within the optical pathway?


    Question 6: How do you manage patient expectations and IOL selection?

    Question 7: How do we measure OPD ROI and monetize the advanced diagnostic test regimen?